ArticleJournal of translational medicine2025
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveal macrophage subpopulation characteristics and the role of STAT1 in rheumatoid arthritis.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Smart Polymer Nanoparticles: Targeting Macrophages/Fibroblasts and Modulating the Microenvironment for Rheumatoid Arthritis Therapy.International journal of nanomedicine · 2026Review
- Transcriptomics and AI-driven approaches to the diagnosis and treatment of rheumatoid arthritis.Frontiers in immunology · 2026Review
- Bulk RNAseq Analysis of Cardiac Myosin-Specific CD4Biomedicines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundRheumatoid arthritis (RA) represents a persistent systemic autoimmune disorder characterized by chronic inflammation and significant disability. Macrophage heterogeneity plays a crucial role in the progression of RA, but the molecular characteristics and regulatory mechanisms of its subsets have not yet been fully elucidated.
methodsIn this study, we integrated single-cell RNA sequencing (scRNA-seq) data and bulk RNA sequencing (bulk RNA-seq) data, and employed multiple strategies for analysis and identification of the heterogeneity of macrophages in RA. We identified STAT1 as a key gene through a combined approach utilizing LASSO regression and random forest models. The differential expression of STAT1 was subsequently validated in an adjuvant-induced arthritis (AIA) rat model. Furthermore, functional experiments were performed to investigate the association of STAT1 with autophagy and ferroptosis pathways.
resultsBased on scRNA-seq data, a total of 26,923 cells were subjected to multi-dimensional analysis. The synovial tissues of RA mice exhibited a markedly elevated percentage of macrophages expressing Stat1. Enrichment analysis indicated that Stat1
conclusionsThis study elucidated the heterogeneity and functional characteristics of macrophage subsets in RA synovial tissue through scRNA-seq and bulk RNA sequencing, and suggested that STAT1 and its downstream signaling pathways may serve as potential therapeutic targets for RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.